Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP76527.RA0uQ3-1DycSPj35mU2NtB7_uJQyzQIjih7pJUnsDlihc130_assertion description "[Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP76527.RA0uQ3-1DycSPj35mU2NtB7_uJQyzQIjih7pJUnsDlihc130_provenance.
• NP190270.RAZi_sAVtHeiusLpfLpIHB1RRhJtOwsosMWiVm8Bh_Iac130_assertion description "[Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP190270.RAZi_sAVtHeiusLpfLpIHB1RRhJtOwsosMWiVm8Bh_Iac130_provenance.
• NP76438.RAttZwg4deYG-mTh6sJ9uHeLYqTSrWWBmys3xeVcNsUzg130_assertion description "[Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP76438.RAttZwg4deYG-mTh6sJ9uHeLYqTSrWWBmys3xeVcNsUzg130_provenance.
• NP76476.RAqyBImgc3CEG2rMb2MPKGbon90r25BQ0cTbBYU3dFkEY130_assertion description "[Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP76476.RAqyBImgc3CEG2rMb2MPKGbon90r25BQ0cTbBYU3dFkEY130_provenance.
• NP593911.RA-rSVzwbm1-DWczzAihUv8i_yPENmQZsLzhfb9Y7ruuk130_assertion description "[Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP593911.RA-rSVzwbm1-DWczzAihUv8i_yPENmQZsLzhfb9Y7ruuk130_provenance.
• assertion description "[Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP111821.RAUB4hj6-yFhuRs6xjjbVWlwXJy5OFHlqPeNR3Aov1DVo130_assertion description "[Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111821.RAUB4hj6-yFhuRs6xjjbVWlwXJy5OFHlqPeNR3Aov1DVo130_provenance.
• NP341443.RAaPZsj3QiAGdyiibb6aVPcXUb0GF35z_a-cuKELEEQNU130_assertion description "[Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP341443.RAaPZsj3QiAGdyiibb6aVPcXUb0GF35z_a-cuKELEEQNU130_provenance.
• NP115383.RAbUMIVMKda7IEfn39ZoFVRjq1GTvxScw7WL89MQnrDjg130_assertion description "[Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP115383.RAbUMIVMKda7IEfn39ZoFVRjq1GTvxScw7WL89MQnrDjg130_provenance.
• NP115386.RAcM-otKpz3FkKTjQcXQmZaLlNZ5mrMg4D8XsZbRP4y-s130_assertion description "[Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP115386.RAcM-otKpz3FkKTjQcXQmZaLlNZ5mrMg4D8XsZbRP4y-s130_provenance.
• NP77279.RAIBzcMfOKi5AJiXywq6Fp76_2EGkGhjD6dts66epoC24130_assertion description "[Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP77279.RAIBzcMfOKi5AJiXywq6Fp76_2EGkGhjD6dts66epoC24130_provenance.
• NP641156.RAjtxWzX6YZmB-O0X6PJHRklSfDVTNeBAa1ehrjy97bIc130_assertion description "[Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641156.RAjtxWzX6YZmB-O0X6PJHRklSfDVTNeBAa1ehrjy97bIc130_provenance.
• NP641157.RAovZbknQ1_mMqU2NjodbmB5xzHbI4g2_-Sj0VgKvmKBE130_assertion description "[Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641157.RAovZbknQ1_mMqU2NjodbmB5xzHbI4g2_-Sj0VgKvmKBE130_provenance.
• NP641159.RAsIwFr9uLuL6y7fvdGznn2P3xb697MMMPOy27Fnm_NZw130_assertion description "[Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641159.RAsIwFr9uLuL6y7fvdGznn2P3xb697MMMPOy27Fnm_NZw130_provenance.
• NP111918.RA5gBrHEE6if2FDNWHLzf6ZYJZFxEqM8pSXkQUy33_Egk130_assertion description "[Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111918.RA5gBrHEE6if2FDNWHLzf6ZYJZFxEqM8pSXkQUy33_Egk130_provenance.
• NP341683.RA0LJRdvkQGgnQBjGn_mKpukMT9dOowUMRQDZWOzWhMQU130_assertion description "[Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP341683.RA0LJRdvkQGgnQBjGn_mKpukMT9dOowUMRQDZWOzWhMQU130_provenance.
• NP641158.RA7bRVWNVslHl9u_z8LmEdEM9P-dS2INo32MPmKNybyME130_assertion description "[Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641158.RA7bRVWNVslHl9u_z8LmEdEM9P-dS2INo32MPmKNybyME130_provenance.
• NP115382.RA7HqOF1EwLEXU31UW8yyF4gYgc771kDq8759cxrcoxRY130_assertion description "[Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP115382.RA7HqOF1EwLEXU31UW8yyF4gYgc771kDq8759cxrcoxRY130_provenance.
• NP115384.RAxkDooSUqcrHh0tds573fr6dhgFeiNSrVTkaEHrRze-k130_assertion description "[Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP115384.RAxkDooSUqcrHh0tds573fr6dhgFeiNSrVTkaEHrRze-k130_provenance.